Senna Syrup
- Product NDC
- 81033-120
- 11-digit product format
- 810330120
- Labeler code
- 81033
- Product ID
- 81033-120_4124d2ca-847d-bb50-e063-6294a90af8f0
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Senna Syrup
- Dosage form
- SYRUP
- Route
- ORAL
- Labeler
- Kesin Pharma Corporation
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-05-26
- Substance
- SENNOSIDES
- Active strength
- 8.8 mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Senna Syrup
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES | 8.8 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3FYP5M0IJX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 702311 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 360fb98d-c6ad-7bcc-e063-6294a90a9453 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-120-05 | Senna Syrup | 5 mL in 1 CUP, UNIT-DOSE | SYRUP | 5 | 2 | |
| 81033-120-10 | Senna Syrup | 10 mL in 1 CUP, UNIT-DOSE | SYRUP | 10 | 2 | |
| 81033-120-15 | Senna Syrup | 15 mL in 1 CUP, UNIT-DOSE | SYRUP | 15 | 2 | |
| 81033-120-50 | Senna Syrup | 50 in 1 CARTON | SYRUP | 50 | 2 | |
| 81033-120-54 | Senna Syrup | 50 in 1 CARTON | SYRUP | 50 | 2 | |
| 81033-120-55 | Senna Syrup | 50 in 1 CARTON | SYRUP | 50 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-120-05 | ML - Milliliter | 81033-120 | 0e75bf43-dba6-48c5-8017-4de9486dbf47 | 1 | 2025-07-08 |
| 81033-120-10 | ML - Milliliter | 81033-120 | 478b4a61-8b55-4a29-8fca-bd0d9d0b556c | 1 | 2025-12-16 |
| 81033-120-15 | ML - Milliliter | 81033-120 | 3642f0b3-e8fb-4663-b2ad-951b82fba924 | 1 | 2025-12-16 |
| 81033-120-50 | ML - Milliliter | 81033-120 | 398d5ce8-fc9e-4655-adc4-04a63e839a21 | 1 | 2025-07-08 |
| 81033-120-54 | ML - Milliliter | 81033-120 | db9146a1-1943-4e6f-9a2d-f25d8a6e2fe5 | 1 | 2025-12-16 |
| 81033-120-55 | ML - Milliliter | 81033-120 | ad25a372-98bb-42ed-9858-bb45610f814d | 1 | 2025-12-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| up and up fiber therapy | PSYLLIUM HUSK | TARGET CORPORATION | 956c48f8-c705-4a86-9866-c68a48ddeb6c | 2026-11-06 | Warnings | M007 |
| Sennosides | SENNOSIDES | REMEDYREPACK INC. | 3873abcd-8312-47d1-bccf-4265e1e32861 | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy | PSYLLIUM HUSK | Target Corporation | 674753ee-1174-4c06-9ed3-a090b338a39e | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy Natural Fiber | PSYLLIUM HUSK | Target Corporation | f8b1c831-6fd0-4a58-9726-4e0f986c8084 | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy | CALCIUM POLYCARBOPHIL | Target Corporation. | e5473950-06f4-4ea4-975b-3ac94957e776 | 2026-11-06 | Warnings | M007 |
| Target Fiber Laxative | PSYLLIUM HUSK | TARGET CORPORATION | a581116a-392d-4ac3-ae15-4318506a7b2a | 2026-11-05 | Warnings | M007 |
| up and up gentle laxative | BISACODYL | Target Corporation | 4a29dc2b-b68f-471b-a84e-4a5096aa3748 | 2026-11-05 | Warnings | M007 |
| Metamucil Therapy for regularity | PSYLLIUM HUSK | The Procter & Gamble Manufacturing Company | a9824f73-5ea2-4a65-a926-3a57561441b8 | 2026-11-04 | Warnings | M007 |
| Colon Detox | DOCUSATE SODIUM AND SENNOSIDES | OPMX LLC | 0a4d3265-080c-d2ed-e063-6394a90adbee | 2026-11-04 | Warnings | M007 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | M007 |
| Fiber Caplets | CALCIUM POLYCARBOPHIL | SAFEWAY | 08e2e8b0-90b3-48d6-a72a-40688c74771a | 2026-11-03 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 9b3b6cea-ab83-4b7c-a425-fd0ac7df426c | 2026-11-02 | Warnings, Adverse reactions | M007 |
| Gentle Laxative Stimulant Laxative | BISACODYL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | bcd3c07d-bd83-4452-9736-35c85db30c15 | 2026-10-29 | Warnings | M007 |
| Quality Choice | CALCIUM POLYCARBOPHIL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f1e69c65-c1b0-459f-9a12-b1a92b90036b | 2026-10-29 | Warnings | M007 |
| CDMA Fiber Therapy | METHYLCELLULOSE | CHAIN DRUG MARKETING ASSOCIATION | 62bbcaf2-1d0c-485f-9159-685700aa3418 | 2026-10-29 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 51ed515b-cc51-4ea1-b612-090476135005 | 2026-10-29 | Warnings, Adverse reactions | M007 |
| Quality Choice Fiber Laxative | PSYLLIUM HUSK | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 2ee637c4-c4c6-4a24-ae99-612205afd592 | 2026-10-29 | Warnings | M007 |
| Magnesium Citrate | EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 4 Visions LLC | 5eeb0d66-06c7-7789-e063-6394a90aaff4 | 2026-10-28 | Warnings | M007 |
| Fiber Lax | CALCIUM POLYCARBOPHIL | PD-Rx Pharmaceuticals, Inc. | 730198a5-b6d9-4fc7-b053-a7c65a93c540 | 2026-10-27 | Warnings | M007 |
| Senna S | DOCUSATE SODIUM AND SENNOSIDES | Marlex Pharmaceuticals Inc | 9c87759f-3856-4f30-b5ea-4b37ed90f18c | 2026-10-27 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | 360fb98d-c6ad-7bcc-e063-6294a90a9453 | 2 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | 360fb98d-c6ad-7bcc-e063-6294a90a9453 | 2 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | 360fb98d-c6ad-7bcc-e063-6294a90a9453 | 2 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | 360fb98d-c6ad-7bcc-e063-6294a90a9453 | 2 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | 360fb98d-c6ad-7bcc-e063-6294a90a9453 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 81033-120-05 | 81033012005 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | |||
| 81033-120-10 | 81033012010 | 10 mL in 1 CUP, UNIT-DOSE | 10 ml | Historical | |||
| 81033-120-15 | 81033012015 | 15 mL in 1 CUP, UNIT-DOSE | 15 ml | Historical | |||
| 81033-120-50 | 81033012050 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-120-50) / 5 mL in 1 CUP, UNIT-DOSE (81033-120-05) | 2025-05-26 | No | No | Current | |
| 81033-120-54 | 81033012054 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-120-54) / 10 mL in 1 CUP, UNIT-DOSE (81033-120-10) | 2025-10-20 | No | No | Current | |
| 81033-120-55 | 81033012055 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-120-55) / 15 mL in 1 CUP, UNIT-DOSE (81033-120-15) | 2025-10-20 | No | No | Current |